Lyell Immunopharma (LYEL) Long-Term Investments (2020 - 2026)
Lyell Immunopharma's Long-Term Investments was $23.9 million in Q2 2026, up 19.1% from $20.06 million a year earlier and up 25.8% from the prior quarter.
Powered by 
Analysis
Lyell Immunopharma (LYEL) Long-Term Investments (2020 - 2026) Analysis & Trends
At the end of FY2025, Long-Term Investments at Lyell Immunopharma came in at $19 million, unchanged from FY2024.
- Long-Term Investments shows a five-year compound annual growth rate of -25.6% (FY2020 to FY2025).
- In earlier years, Long-Term Investments was $19 million in FY2024 (-40.6%), $32 million in FY2023 (-54.4%), $70.12 million in FY2022 (-75.3%) and $283.53 million in FY2021 (+239.8%).
- The Q2 2026 figure marks the highest quarterly Long-Term Investments since Q1 2025.
- Compared with a year earlier, Long-Term Investments was higher in three of the last eight quarters, with an average decline of 5.1%.
- The best year-over-year quarter for Long-Term Investments over five years was Q4 2021 (growth of 239.8%); the worst was Q1 2023 (a decline of 75.3%).
- Per Business Quant data, LYEL's Long-Term Investments in the three quarters before Q2 2026 was $19 million (Q1 2026), $19 million (Q4 2025) and $19 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.86 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | - |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 266.00 Mn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 1.22 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 69.00 Mn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 2.62 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | - |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 1.56 Bn |
| 10 | Lyell Immunopharma | 220.17 Mn | 220.17 Mn | - | 23.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.90 Mn |
| Mar 31, 2026 | 19.00 Mn |
| Dec 31, 2025 | 19.00 Mn |
| Sep 30, 2025 | 19.00 Mn |
| Jun 30, 2025 | 20.06 Mn |
| Mar 31, 2025 | 28.95 Mn |
| Dec 31, 2024 | 19.00 Mn |
| Sep 30, 2024 | 20.11 Mn |
| Jun 30, 2024 | 19.00 Mn |
| Mar 31, 2024 | 19.00 Mn |
| Dec 31, 2023 | 32.00 Mn |
| Sep 30, 2023 | 32.00 Mn |
| Jun 30, 2023 | 36.95 Mn |
| Mar 31, 2023 | 55.26 Mn |
| Dec 31, 2022 | 70.12 Mn |
| Sep 30, 2022 | 102.52 Mn |
| Jun 30, 2022 | 131.44 Mn |
| Mar 31, 2022 | 224.12 Mn |
| Dec 31, 2021 | 283.53 Mn |
| Sep 30, 2021 | 317.51 Mn |
API Access
Lyell Immunopharma Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=LYEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "LYEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=LYEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();